Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Amyloid beta-Protein Precursor | 33 | 2023 | 1117 | 5.260 |
Why?
|
5' Untranslated Regions | 20 | 2020 | 255 | 3.510 |
Why?
|
Protein Biosynthesis | 25 | 2023 | 2094 | 2.860 |
Why?
|
Ferritins | 15 | 2020 | 601 | 2.110 |
Why?
|
Iron-Regulatory Proteins | 9 | 2020 | 30 | 1.970 |
Why?
|
Iron | 25 | 2023 | 1813 | 1.960 |
Why?
|
alpha-Synuclein | 8 | 2020 | 773 | 1.760 |
Why?
|
Alzheimer Disease | 36 | 2023 | 8759 | 1.630 |
Why?
|
Manganese Poisoning | 2 | 2019 | 13 | 1.290 |
Why?
|
Neurodegenerative Diseases | 6 | 2020 | 1094 | 0.930 |
Why?
|
RNA, Messenger | 29 | 2019 | 12801 | 0.930 |
Why?
|
Response Elements | 6 | 2019 | 308 | 0.930 |
Why?
|
Manganese | 2 | 2024 | 394 | 0.890 |
Why?
|
Interleukin-1 | 9 | 2008 | 1252 | 0.870 |
Why?
|
Neuroprotective Agents | 5 | 2024 | 958 | 0.840 |
Why?
|
Iron Regulatory Protein 1 | 4 | 2013 | 40 | 0.810 |
Why?
|
Amyloid beta-Peptides | 12 | 2023 | 3914 | 0.770 |
Why?
|
Neuroblastoma | 5 | 2024 | 1266 | 0.660 |
Why?
|
Parkinson Disease | 7 | 2020 | 2893 | 0.650 |
Why?
|
Lead Poisoning, Nervous System | 1 | 2019 | 12 | 0.650 |
Why?
|
Quinuclidines | 1 | 2019 | 27 | 0.640 |
Why?
|
Apoferritins | 1 | 2018 | 17 | 0.640 |
Why?
|
Muscarinic Agonists | 1 | 2019 | 91 | 0.630 |
Why?
|
Chelating Agents | 6 | 2010 | 385 | 0.590 |
Why?
|
S-Adenosylmethionine | 2 | 2019 | 219 | 0.570 |
Why?
|
Metals | 5 | 2010 | 713 | 0.560 |
Why?
|
Homeostasis | 5 | 2016 | 3348 | 0.510 |
Why?
|
Protein Synthesis Inhibitors | 3 | 2006 | 188 | 0.490 |
Why?
|
Deferoxamine | 5 | 2016 | 155 | 0.490 |
Why?
|
Small Molecule Libraries | 1 | 2020 | 742 | 0.480 |
Why?
|
Thiophenes | 1 | 2019 | 570 | 0.470 |
Why?
|
Oxidative Stress | 4 | 2018 | 3140 | 0.460 |
Why?
|
Physostigmine | 3 | 2013 | 50 | 0.460 |
Why?
|
Drugs, Investigational | 2 | 2006 | 211 | 0.440 |
Why?
|
Neurons | 9 | 2020 | 9514 | 0.420 |
Why?
|
Paroxetine | 4 | 2006 | 181 | 0.410 |
Why?
|
Iron Chelating Agents | 3 | 2016 | 141 | 0.410 |
Why?
|
Neurotoxicity Syndromes | 1 | 2016 | 302 | 0.400 |
Why?
|
Transcription Factor AP-1 | 2 | 2016 | 321 | 0.380 |
Why?
|
Dicloxacillin | 1 | 2011 | 9 | 0.370 |
Why?
|
Strophanthidin | 1 | 2011 | 15 | 0.370 |
Why?
|
Cardenolides | 1 | 2011 | 17 | 0.370 |
Why?
|
Lead | 1 | 2016 | 882 | 0.350 |
Why?
|
Drug Evaluation, Preclinical | 5 | 2006 | 1339 | 0.340 |
Why?
|
Amyloid Precursor Protein Secretases | 4 | 2022 | 616 | 0.340 |
Why?
|
Alcoholism | 1 | 2020 | 1980 | 0.330 |
Why?
|
Erythromycin | 2 | 2006 | 115 | 0.330 |
Why?
|
Nucleic Acid Conformation | 4 | 2010 | 901 | 0.320 |
Why?
|
Neurofibrillary Tangles | 1 | 2011 | 459 | 0.300 |
Why?
|
Interleukin-1beta | 3 | 2016 | 1028 | 0.300 |
Why?
|
Transfection | 10 | 2006 | 5756 | 0.300 |
Why?
|
Acetylcysteine | 2 | 2006 | 262 | 0.300 |
Why?
|
Gene Expression Regulation | 10 | 2020 | 11930 | 0.290 |
Why?
|
Cell Line, Tumor | 14 | 2024 | 17142 | 0.290 |
Why?
|
Cell Survival | 5 | 2024 | 5789 | 0.290 |
Why?
|
I-kappa B Proteins | 1 | 2008 | 210 | 0.290 |
Why?
|
Brain | 13 | 2020 | 27362 | 0.290 |
Why?
|
Dimercaprol | 2 | 2004 | 7 | 0.280 |
Why?
|
Interleukin-6 | 4 | 2016 | 3229 | 0.280 |
Why?
|
Ferric Compounds | 1 | 2009 | 376 | 0.280 |
Why?
|
Enzyme Activators | 1 | 2007 | 56 | 0.280 |
Why?
|
Iron-Sulfur Proteins | 5 | 2001 | 84 | 0.260 |
Why?
|
Untranslated Regions | 1 | 2006 | 30 | 0.260 |
Why?
|
Base Sequence | 14 | 2013 | 12422 | 0.260 |
Why?
|
Cholinesterase Inhibitors | 2 | 2004 | 241 | 0.260 |
Why?
|
Drug Design | 2 | 2010 | 1046 | 0.260 |
Why?
|
Lewy Bodies | 2 | 2020 | 141 | 0.250 |
Why?
|
ADAM Proteins | 1 | 2006 | 242 | 0.240 |
Why?
|
Siderophores | 1 | 2004 | 61 | 0.230 |
Why?
|
Genes, Reporter | 8 | 2013 | 1524 | 0.230 |
Why?
|
Animals | 41 | 2022 | 169285 | 0.230 |
Why?
|
Molecular Sequence Data | 12 | 2013 | 17623 | 0.220 |
Why?
|
Metals, Heavy | 1 | 2004 | 149 | 0.210 |
Why?
|
Tumor Cells, Cultured | 12 | 2006 | 6124 | 0.200 |
Why?
|
Mental Disorders | 2 | 2019 | 6873 | 0.190 |
Why?
|
Chloramphenicol O-Acetyltransferase | 4 | 2005 | 221 | 0.180 |
Why?
|
Receptors, Cell Surface | 1 | 2010 | 2819 | 0.180 |
Why?
|
Signal Transduction | 9 | 2018 | 23648 | 0.180 |
Why?
|
Humans | 72 | 2024 | 768171 | 0.180 |
Why?
|
Regulatory Sequences, Nucleic Acid | 3 | 2013 | 792 | 0.180 |
Why?
|
Drug Approval | 2 | 2005 | 821 | 0.180 |
Why?
|
Astrocytes | 2 | 2006 | 1350 | 0.170 |
Why?
|
Mice, Transgenic | 6 | 2020 | 9561 | 0.170 |
Why?
|
RNA-Binding Proteins | 6 | 2001 | 1891 | 0.170 |
Why?
|
Mitragyna | 1 | 2019 | 16 | 0.170 |
Why?
|
Dose-Response Relationship, Drug | 7 | 2006 | 10763 | 0.170 |
Why?
|
Mice | 16 | 2022 | 82049 | 0.160 |
Why?
|
Protein Modification, Translational | 1 | 2018 | 21 | 0.160 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2008 | 2885 | 0.160 |
Why?
|
Rats | 10 | 2019 | 23782 | 0.150 |
Why?
|
Enhancer Elements, Genetic | 3 | 2005 | 1367 | 0.150 |
Why?
|
Down Syndrome | 2 | 2019 | 919 | 0.150 |
Why?
|
Luciferases | 3 | 2005 | 713 | 0.140 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 1999 | 355 | 0.140 |
Why?
|
Copper | 1 | 2020 | 368 | 0.140 |
Why?
|
Cannabidiol | 1 | 2019 | 123 | 0.140 |
Why?
|
Protein Binding | 8 | 2013 | 9343 | 0.140 |
Why?
|
Lysosomes | 1 | 2023 | 938 | 0.140 |
Why?
|
Growth Hormone | 1 | 1999 | 573 | 0.130 |
Why?
|
Sequence Homology, Nucleic Acid | 3 | 2013 | 1057 | 0.130 |
Why?
|
Amyloid | 2 | 2016 | 853 | 0.130 |
Why?
|
Acute-Phase Reaction | 1 | 1996 | 91 | 0.130 |
Why?
|
Receptors, Transferrin | 3 | 2008 | 300 | 0.130 |
Why?
|
Cell Line | 6 | 2018 | 15602 | 0.130 |
Why?
|
Inflammation Mediators | 1 | 2004 | 1892 | 0.130 |
Why?
|
Ghrelin | 1 | 2017 | 251 | 0.120 |
Why?
|
Plaque, Amyloid | 3 | 2022 | 769 | 0.120 |
Why?
|
Methylation | 1 | 2018 | 1078 | 0.120 |
Why?
|
Protein Multimerization | 1 | 2020 | 966 | 0.120 |
Why?
|
Ferrosoferric Oxide | 1 | 2016 | 348 | 0.120 |
Why?
|
Clioquinol | 2 | 2006 | 23 | 0.120 |
Why?
|
MicroRNAs | 2 | 2022 | 3803 | 0.120 |
Why?
|
Blotting, Western | 2 | 2013 | 5028 | 0.120 |
Why?
|
Enterocytes | 1 | 2016 | 220 | 0.120 |
Why?
|
Triiodothyronine | 1 | 1996 | 492 | 0.120 |
Why?
|
Codon | 1 | 1996 | 599 | 0.110 |
Why?
|
Pharmaceutical Preparations | 1 | 2002 | 1088 | 0.110 |
Why?
|
Anti-Bacterial Agents | 2 | 2011 | 7477 | 0.110 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2013 | 3806 | 0.110 |
Why?
|
Iron Metabolism Disorders | 1 | 2014 | 24 | 0.110 |
Why?
|
NM23 Nucleoside Diphosphate Kinases | 1 | 2013 | 21 | 0.110 |
Why?
|
Hemopexin | 1 | 2013 | 33 | 0.110 |
Why?
|
Reactive Oxygen Species | 2 | 2018 | 2152 | 0.100 |
Why?
|
Gene Order | 1 | 2013 | 166 | 0.100 |
Why?
|
Monoamine Oxidase | 1 | 2012 | 180 | 0.090 |
Why?
|
Memantine | 1 | 2012 | 111 | 0.090 |
Why?
|
Dementia, Vascular | 1 | 2012 | 125 | 0.090 |
Why?
|
Cells, Cultured | 5 | 2013 | 19025 | 0.090 |
Why?
|
Autistic Disorder | 1 | 2020 | 1240 | 0.090 |
Why?
|
Environmental Pollutants | 1 | 2020 | 1296 | 0.090 |
Why?
|
Catecholamines | 1 | 2012 | 389 | 0.090 |
Why?
|
Protease Nexins | 1 | 2010 | 39 | 0.090 |
Why?
|
Ceruloplasmin | 1 | 2010 | 57 | 0.090 |
Why?
|
Chelation Therapy | 1 | 2010 | 77 | 0.090 |
Why?
|
Rats, Sprague-Dawley | 2 | 2018 | 8142 | 0.090 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 2 | 2016 | 440 | 0.090 |
Why?
|
Environmental Exposure | 2 | 2020 | 4543 | 0.080 |
Why?
|
Antioxidants | 2 | 2010 | 1676 | 0.080 |
Why?
|
Caco-2 Cells | 2 | 2008 | 367 | 0.080 |
Why?
|
Acute-Phase Proteins | 1 | 1990 | 252 | 0.080 |
Why?
|
Membrane Proteins | 1 | 2006 | 7876 | 0.080 |
Why?
|
DNA | 6 | 2013 | 7213 | 0.080 |
Why?
|
Child Development | 1 | 2020 | 2330 | 0.080 |
Why?
|
Protein Processing, Post-Translational | 2 | 2009 | 1966 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2006 | 4585 | 0.080 |
Why?
|
Levodopa | 1 | 2009 | 221 | 0.080 |
Why?
|
Acute Disease | 1 | 2019 | 7243 | 0.080 |
Why?
|
Benzimidazoles | 1 | 2013 | 864 | 0.070 |
Why?
|
Cytokines | 1 | 2003 | 7452 | 0.070 |
Why?
|
Aniline Compounds | 1 | 2013 | 1094 | 0.070 |
Why?
|
Promoter Regions, Genetic | 2 | 2010 | 5797 | 0.070 |
Why?
|
Carcinoma, Hepatocellular | 6 | 2005 | 2334 | 0.070 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2012 | 903 | 0.070 |
Why?
|
Enzyme Inhibitors | 2 | 2008 | 3728 | 0.070 |
Why?
|
Amyloid Neuropathies | 1 | 2006 | 15 | 0.070 |
Why?
|
Zinc | 1 | 2010 | 677 | 0.070 |
Why?
|
Nitric Oxide | 1 | 2015 | 2149 | 0.060 |
Why?
|
Poly C | 1 | 2005 | 6 | 0.060 |
Why?
|
Hydrolysis | 1 | 2007 | 646 | 0.060 |
Why?
|
Principal Component Analysis | 1 | 2008 | 948 | 0.060 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2006 | 308 | 0.060 |
Why?
|
Transcriptional Activation | 2 | 2018 | 1750 | 0.060 |
Why?
|
RNA, Double-Stranded | 1 | 2006 | 292 | 0.060 |
Why?
|
Consensus Sequence | 2 | 1996 | 363 | 0.060 |
Why?
|
Mutation | 2 | 2013 | 30237 | 0.060 |
Why?
|
Receptors, Glucagon | 1 | 2004 | 90 | 0.060 |
Why?
|
Drug Interactions | 2 | 2006 | 1419 | 0.060 |
Why?
|
Mice, Inbred C57BL | 3 | 2018 | 22380 | 0.060 |
Why?
|
Synaptic Transmission | 1 | 2010 | 1177 | 0.060 |
Why?
|
Epigenesis, Genetic | 1 | 2018 | 3833 | 0.060 |
Why?
|
Pregnancy Proteins | 1 | 2005 | 222 | 0.060 |
Why?
|
Peptide Fragments | 4 | 2006 | 5151 | 0.060 |
Why?
|
Spectrometry, Fluorescence | 1 | 2006 | 694 | 0.060 |
Why?
|
Gene Expression | 2 | 2008 | 7601 | 0.060 |
Why?
|
Apolipoproteins E | 1 | 2010 | 1461 | 0.060 |
Why?
|
Technology, Pharmaceutical | 1 | 2004 | 84 | 0.050 |
Why?
|
DNA Methylation | 1 | 2018 | 4428 | 0.050 |
Why?
|
Macaca mulatta | 1 | 2010 | 2363 | 0.050 |
Why?
|
Oxidoreductases | 1 | 2005 | 410 | 0.050 |
Why?
|
Oxidation-Reduction | 2 | 2012 | 2227 | 0.050 |
Why?
|
Immunoprecipitation | 1 | 2005 | 874 | 0.050 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2004 | 348 | 0.050 |
Why?
|
Transgenes | 1 | 2006 | 1016 | 0.050 |
Why?
|
Pattern Recognition, Automated | 1 | 2008 | 993 | 0.050 |
Why?
|
Ultraviolet Rays | 2 | 2005 | 1103 | 0.050 |
Why?
|
HeLa Cells | 3 | 2018 | 3074 | 0.050 |
Why?
|
Protein Structure, Secondary | 1 | 2005 | 1216 | 0.050 |
Why?
|
Phosphorylation | 2 | 2016 | 8316 | 0.050 |
Why?
|
Pilot Projects | 2 | 2006 | 8741 | 0.050 |
Why?
|
Algorithms | 3 | 2013 | 14164 | 0.050 |
Why?
|
Immunoblotting | 1 | 2005 | 1648 | 0.050 |
Why?
|
Cloning, Molecular | 3 | 2003 | 4168 | 0.050 |
Why?
|
Up-Regulation | 3 | 2018 | 4149 | 0.050 |
Why?
|
Iron-Binding Proteins | 1 | 2001 | 83 | 0.050 |
Why?
|
Azithromycin | 1 | 2003 | 201 | 0.050 |
Why?
|
Biotin | 1 | 2022 | 256 | 0.050 |
Why?
|
Liver | 6 | 2005 | 7578 | 0.050 |
Why?
|
RNA | 2 | 2009 | 2722 | 0.050 |
Why?
|
Plasmids | 2 | 2005 | 2269 | 0.050 |
Why?
|
Models, Biological | 2 | 2008 | 9497 | 0.050 |
Why?
|
Pheochromocytoma | 1 | 2003 | 328 | 0.050 |
Why?
|
Thyrotropin-Releasing Hormone | 1 | 2000 | 139 | 0.040 |
Why?
|
Cytoplasm | 1 | 2005 | 1505 | 0.040 |
Why?
|
Enzyme Activation | 1 | 2006 | 3590 | 0.040 |
Why?
|
Organometallic Compounds | 1 | 2004 | 648 | 0.040 |
Why?
|
Recombinant Proteins | 2 | 2005 | 6512 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2008 | 2459 | 0.040 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 1999 | 1730 | 0.040 |
Why?
|
Cluster Analysis | 3 | 2013 | 2732 | 0.040 |
Why?
|
Melatonin | 1 | 2004 | 670 | 0.040 |
Why?
|
Sequence Alignment | 2 | 2010 | 2179 | 0.040 |
Why?
|
Cation Transport Proteins | 1 | 2001 | 326 | 0.040 |
Why?
|
Magnesium | 1 | 2002 | 816 | 0.040 |
Why?
|
Leukemia, Erythroblastic, Acute | 1 | 1999 | 176 | 0.040 |
Why?
|
Astrocytoma | 1 | 2003 | 774 | 0.040 |
Why?
|
Presenilin-1 | 1 | 2022 | 666 | 0.040 |
Why?
|
Thalidomide | 1 | 2004 | 886 | 0.040 |
Why?
|
Amino Acid Sequence | 5 | 2010 | 13422 | 0.040 |
Why?
|
Protein Structure, Tertiary | 1 | 2005 | 3772 | 0.040 |
Why?
|
tau Proteins | 1 | 2008 | 2144 | 0.040 |
Why?
|
Pituitary Gland | 1 | 2000 | 634 | 0.040 |
Why?
|
Epidermal Growth Factor | 1 | 2000 | 697 | 0.040 |
Why?
|
Computational Biology | 1 | 2010 | 3567 | 0.040 |
Why?
|
RNA Precursors | 1 | 2018 | 196 | 0.040 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2003 | 735 | 0.040 |
Why?
|
Gene Expression Profiling | 2 | 2010 | 9540 | 0.030 |
Why?
|
Amyloidosis | 1 | 2004 | 877 | 0.030 |
Why?
|
Cross Reactions | 1 | 1999 | 828 | 0.030 |
Why?
|
Hair | 1 | 2020 | 508 | 0.030 |
Why?
|
Antibody Specificity | 1 | 1999 | 1065 | 0.030 |
Why?
|
Down-Regulation | 1 | 2004 | 2939 | 0.030 |
Why?
|
Liver Neoplasms | 4 | 1999 | 4363 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase 8 | 1 | 2016 | 71 | 0.030 |
Why?
|
Protein Kinase C | 1 | 2000 | 1207 | 0.030 |
Why?
|
Models, Molecular | 1 | 2006 | 5402 | 0.030 |
Why?
|
Holography | 1 | 2016 | 80 | 0.030 |
Why?
|
Receptors, Thyroid Hormone | 1 | 1996 | 202 | 0.030 |
Why?
|
Intelligence | 1 | 2020 | 926 | 0.030 |
Why?
|
MPTP Poisoning | 1 | 2015 | 37 | 0.030 |
Why?
|
Inflammation | 3 | 2013 | 10873 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2004 | 2956 | 0.030 |
Why?
|
Spectrum Analysis | 1 | 2016 | 449 | 0.030 |
Why?
|
Canada | 1 | 2019 | 2130 | 0.030 |
Why?
|
Organ Culture Techniques | 1 | 2016 | 796 | 0.030 |
Why?
|
Age of Onset | 1 | 2020 | 3346 | 0.030 |
Why?
|
Apoproteins | 1 | 2013 | 45 | 0.030 |
Why?
|
Substantia Nigra | 1 | 2015 | 346 | 0.030 |
Why?
|
Poly A | 1 | 1993 | 180 | 0.030 |
Why?
|
Serum Amyloid A Protein | 1 | 1993 | 128 | 0.030 |
Why?
|
Drug Delivery Systems | 1 | 2004 | 2237 | 0.030 |
Why?
|
Peroxides | 1 | 2013 | 76 | 0.030 |
Why?
|
PC12 Cells | 1 | 2013 | 317 | 0.030 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 693 | 0.030 |
Why?
|
Transcription Factors | 2 | 2016 | 12171 | 0.030 |
Why?
|
Neoplasm Proteins | 1 | 2004 | 3604 | 0.030 |
Why?
|
Enzyme Induction | 1 | 2013 | 455 | 0.030 |
Why?
|
Rabbits | 1 | 1999 | 4773 | 0.030 |
Why?
|
Receptors, Muscarinic | 1 | 2013 | 157 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2004 | 4355 | 0.030 |
Why?
|
Epitopes | 1 | 1999 | 2527 | 0.020 |
Why?
|
Biological Transport | 2 | 2001 | 2085 | 0.020 |
Why?
|
Stereoisomerism | 1 | 2013 | 612 | 0.020 |
Why?
|
Species Specificity | 1 | 1996 | 2415 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2004 | 3703 | 0.020 |
Why?
|
Ascorbic Acid | 1 | 1995 | 658 | 0.020 |
Why?
|
Iron Regulatory Protein 2 | 2 | 2001 | 43 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 2 | 1990 | 1305 | 0.020 |
Why?
|
Fasting | 1 | 2017 | 1610 | 0.020 |
Why?
|
Heme | 1 | 2013 | 316 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2004 | 4206 | 0.020 |
Why?
|
Polyribosomes | 1 | 1990 | 109 | 0.020 |
Why?
|
Glioblastoma | 1 | 2006 | 3464 | 0.020 |
Why?
|
Mice, SCID | 1 | 2016 | 2627 | 0.020 |
Why?
|
Heme Oxygenase-1 | 1 | 2013 | 365 | 0.020 |
Why?
|
Blotting, Southwestern | 1 | 2010 | 2 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2010 | 16044 | 0.020 |
Why?
|
Conserved Sequence | 1 | 2013 | 1162 | 0.020 |
Why?
|
Receptors, Nicotinic | 1 | 2013 | 494 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2010 | 294 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2018 | 4280 | 0.020 |
Why?
|
Calcium | 1 | 2002 | 5792 | 0.020 |
Why?
|
Swine | 1 | 1999 | 5997 | 0.020 |
Why?
|
Endocytosis | 1 | 2013 | 957 | 0.020 |
Why?
|
Protein Conformation | 1 | 1996 | 3956 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2012 | 1535 | 0.020 |
Why?
|
Least-Squares Analysis | 1 | 2008 | 367 | 0.020 |
Why?
|
Organ Specificity | 1 | 2013 | 1968 | 0.020 |
Why?
|
Macromolecular Substances | 1 | 1990 | 1435 | 0.020 |
Why?
|
RNA, Neoplasm | 1 | 1990 | 749 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 1996 | 3740 | 0.020 |
Why?
|
NF-kappa B | 1 | 2016 | 2494 | 0.020 |
Why?
|
Oxygen | 1 | 1999 | 4270 | 0.020 |
Why?
|
Intestines | 1 | 2016 | 1909 | 0.020 |
Why?
|
YY1 Transcription Factor | 1 | 2006 | 60 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2012 | 1676 | 0.020 |
Why?
|
Aging | 1 | 2004 | 8743 | 0.020 |
Why?
|
DNA Primers | 1 | 2010 | 2828 | 0.020 |
Why?
|
Glucose | 1 | 2017 | 4352 | 0.020 |
Why?
|
Tumor Necrosis Factor Decoy Receptors | 1 | 2004 | 8 | 0.020 |
Why?
|
Brain Neoplasms | 2 | 2004 | 9118 | 0.020 |
Why?
|
Cognition | 1 | 2022 | 7073 | 0.010 |
Why?
|
Dopamine | 1 | 2012 | 1592 | 0.010 |
Why?
|
Trace Elements | 1 | 2006 | 193 | 0.010 |
Why?
|
Apolipoproteins C | 1 | 1984 | 59 | 0.010 |
Why?
|
Binding Sites | 1 | 2013 | 6019 | 0.010 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2006 | 500 | 0.010 |
Why?
|
Lymphocytes | 1 | 2012 | 2614 | 0.010 |
Why?
|
Time Factors | 1 | 2005 | 40220 | 0.010 |
Why?
|
United States | 2 | 2019 | 73039 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1999 | 9262 | 0.010 |
Why?
|
Apolipoproteins | 1 | 1984 | 328 | 0.010 |
Why?
|
Cations, Divalent | 1 | 2001 | 167 | 0.010 |
Why?
|
Cerebral Hemorrhage | 1 | 2013 | 2654 | 0.010 |
Why?
|
Cell Death | 1 | 2006 | 1680 | 0.010 |
Why?
|
Fibroblasts | 1 | 2012 | 4178 | 0.010 |
Why?
|
Brain Injuries | 1 | 2013 | 2057 | 0.010 |
Why?
|
Brain Chemistry | 1 | 2004 | 958 | 0.010 |
Why?
|
Ribonuclease T1 | 1 | 1999 | 3 | 0.010 |
Why?
|
Heart Rate | 1 | 2012 | 4214 | 0.010 |
Why?
|
Genome, Human | 1 | 2013 | 4446 | 0.010 |
Why?
|
Neoplasms | 1 | 2008 | 22371 | 0.010 |
Why?
|
3' Untranslated Regions | 1 | 2001 | 515 | 0.010 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2000 | 826 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2017 | 22290 | 0.010 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2001 | 393 | 0.010 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2000 | 327 | 0.010 |
Why?
|
Cross-Linking Reagents | 1 | 1999 | 693 | 0.010 |
Why?
|
Models, Neurological | 1 | 2004 | 1776 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2012 | 14488 | 0.010 |
Why?
|
Female | 4 | 2020 | 397187 | 0.010 |
Why?
|
Thyrotropin | 1 | 1999 | 834 | 0.010 |
Why?
|
Blood Pressure | 1 | 2012 | 8543 | 0.010 |
Why?
|
Surface Properties | 1 | 1999 | 1166 | 0.010 |
Why?
|
Models, Genetic | 1 | 2006 | 3447 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2000 | 1246 | 0.010 |
Why?
|
Genotype | 1 | 2010 | 13045 | 0.010 |
Why?
|
Protein Isoforms | 1 | 1999 | 1715 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2006 | 4413 | 0.010 |
Why?
|
MAP Kinase Signaling System | 1 | 2000 | 1495 | 0.010 |
Why?
|
Dactinomycin | 1 | 1993 | 305 | 0.010 |
Why?
|
Drug Stability | 1 | 1993 | 292 | 0.010 |
Why?
|
Heparin | 1 | 1999 | 1636 | 0.010 |
Why?
|
Child | 1 | 2020 | 80917 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2006 | 5804 | 0.010 |
Why?
|
Culture Media, Conditioned | 1 | 1993 | 521 | 0.010 |
Why?
|
Dietary Supplements | 1 | 2004 | 3445 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1993 | 1553 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2004 | 11095 | 0.010 |
Why?
|
Aged | 2 | 2017 | 171502 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2010 | 18065 | 0.000 |
Why?
|
Male | 2 | 2017 | 364731 | 0.000 |
Why?
|
Leukemia | 1 | 1995 | 1519 | 0.000 |
Why?
|
Kinetics | 1 | 1993 | 6330 | 0.000 |
Why?
|
Apolipoprotein C-II | 1 | 1984 | 15 | 0.000 |
Why?
|
Mitochondria, Liver | 1 | 1985 | 190 | 0.000 |
Why?
|
alpha 1-Antitrypsin | 1 | 1985 | 169 | 0.000 |
Why?
|
Genes | 1 | 1988 | 1824 | 0.000 |
Why?
|
RNA, Ribosomal | 1 | 1985 | 227 | 0.000 |
Why?
|
Monocytes | 1 | 1993 | 2605 | 0.000 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 1999 | 8648 | 0.000 |
Why?
|
Middle Aged | 1 | 2017 | 223487 | 0.000 |
Why?
|
Albumins | 1 | 1985 | 577 | 0.000 |
Why?
|
Risk Factors | 1 | 2006 | 74944 | 0.000 |
Why?
|
Intestinal Mucosa | 1 | 1984 | 3044 | 0.000 |
Why?
|
Breast Neoplasms | 1 | 1999 | 21207 | 0.000 |
Why?
|